Author

S. M. Turaga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

D. J. Silver· 3 shared D. Bayik· 2 shared J. Lathia· 2 shared U. Naik· 2 shared A. Lauko· 1 shared A. Steffens· 1 shared A. Trestan· 1 shared C. Braley· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. J. Silver

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SerpinB3 drives cancer stem cell survival in glioblastoma

A. Lauko, J. Volovetz, S. M. Turaga, D. Bayik, D. C. Watson, D. J. Silver, K. Mitchell, E. Mulkearns-Hubert, K. Desai, M. Midha, J. Hao, K. McCortney, A. Steffens, U. Naik, M. S. Ahluwalia, , J. D. Lathia

This study identifies SerpinB3 as a key driver of glioblastoma cancer stem cell survival and shows that targeting it enhances radiation therapy efficacy in pre-clinical models.

bioRxiv · Dec 21, 2021Cancer Biology

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

K. K. Crean-Tate, C. Braley, G. Dey, E. Esakov, C. Saygin, A. Trestan, D. J. Silver, S. M. Turaga, E. V. Connor, R. Debernardo, C. M. Michener, P. G. Rose, J. Lathia, O. Reizes

This study shows that pretreatment with LCK inhibitors makes cisplatin-resistant endometrioid ovarian tumors more sensitive to cisplatin, improving cell viability and tumor growth inhibition.

bioRxiv · Jun 18, 2020Cancer Biology

JAM-A functions as a female microglial tumor suppressor in glioblastoma

S. M. Turaga, D. J. Silver, D. Bayik, E. Paouri, S. Peng, N. Borjini, S. Stanko, U. Naik, R. A. Keri, J. R. Connor, J. Barnholtz-Sloan, J. B. Rubin, M. Berens, D. Davalos, J. Lathia

This study shows that JAM-A deficiency in female mice increases microglia activation and GBM growth, revealing a sex-specific role for JAM-A in the tumor microenvironment.

bioRxiv · Sep 11, 2019Cancer Biology